Vaccines in Fast-Dissolving Tablets: Novel Product Format to Ensure Vaccine Effectiveness, Affordability, and Ease of Use

This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations that are manufactured using a standard lyophilization process. The small tablets are packaged in unit-dose blisters offering an inexpensive, scalable, and easy-to-use product presentation for live attenuated vaccines containing single or multiple bacterial strains. Further, the stackable product presentation may minimize product volume and thus the space required for storage and transport, resulting in significant savings from a health system and cold chain capacity perspective.

Author(s): PATH

Published: 2012